ArticleNeuro-oncology advances

Development of an integrated risk stratification model for metastatic medulloblastoma (M2/3) using clinical, radiologic, and molecular variables.

Wen-Tao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.